Inflammatory pathogenesis in Alzheimer's disease: Biological mechanisms and cognitive sequeli

Neuroscience and Biobehavioral Reviews

Volumn 23, Issue 5, 1999, Pages 615-633

  Gahtan, Ethan ^a   Overmier, J Bruce ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acetylcholine; Alzheimer's pathogenesis; Amyloid; Brain inflammation; Cognition; Cytokines; Free radicals; Glutamate; Microglia; Nitric oxide

Indexed keywords

ACETYLCHOLINE; AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; CYTOKINE; GLUTAMIC ACID; NITRIC OXIDE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; GLIA CELL; HUMAN; LEARNING DISORDER; MEMORY; MOUSE; NERVE INJURY; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; HUMANS; INFLAMMATION;

EID: 0033013760     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(98)00058-X     Document Type: Article

References (197)

1. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology. London: Saunders, 1994.
2. Aisen P.S., Davis K.L. Inflammatory mechansims in Alzheimer's disease: Implications for therapy. Am J Psychiatry. 151:(8):1994;1105-1113.
3. Ancolio K., Marambaud P., Dauch P., Checler F. Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem. 69:(6):1997;2494-2499.
4. Anisman H., Kokkinidis L., Borowski T., Merali Z. Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Res. 779:1998;177-187.
5. Araujo D.M., Lapchak P., Collier B., Quirion R. Localization of IL-2 immunoreactivity and IL-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 489:1989;257-266.
6. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
7. Aubert A., Vega C., Dantzer R., Goodall G. Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Beh Immun. 9:1995;129-148.
8. Aurbach J.M., Segal M. Muscarinic receptors mediating depression and long-term potentiation in rat hippocampus. J Physiol. 492:(2):1996;479-493.
9. Baker L.M., Hauss-Wegrzyniak B., Stoehr J.D., Wenk G.L. Neuroinflammation destroys basal forebrain cholinergic neurons in a time dependent manner. Society for Neuroscience Abstracts. 23:(2):1997;2428.
10. Ban E., Haour F., Lenstra R. Brain interleukin-1 gene expression induced by peripheral lippopolysaccharide administration. Cytokine. 4:(1):1992;48-54.
11. Banks W.A., Kastin R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 2:(4):1995;241-248.
12. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388:1997;878-881.
13. Barger S.W., Van Eldik L.J., Mattson M.P. S100β protects hippocampal neurons from damage induced by glucose deprivation Brain Res. 677:(1):1995;167-170.
14. Barnum S.R. Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med. 6:(2):1995;132-146.
15. Bauer J., Strauss S., Scheiter-Gasser U., Ganter U., Schlegel P., Witt I., Yolk B., Berger M. Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. Febs L. 285:(1):1991;111-114.
16. Benelli A., Bertolini A.L., Poggioli R., Cavazzuti L., Giardino L.M., Arletti R. Nitric oxide is involved in male sexual behaviour of rats. Eur J Pharmacol. 294:(2-3):1995;505-510.
17. Benveniste EN. Cytokine expression in the nervous system. In: Keane RW, Hickey WF, editors. Immunology of the Nervous System. Oxford: Oxford University Press, 1997. p. 419-459.
18. Bhat N.R., Zhang P., Lee J.C., Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci. 18:(5):1998;1633-1641.
19. Bonaiuto C., McDonald P.P., Rossi F., Cassatella M.A. Activation of nuclear factor-kappa B by beta-amyloid peptides and interferon-gamma in murine microglia. J Neuroimmunol. 77:(1):1997;51-56.
20. Bonkale W.L., Winblad B., Ravid R., Cowburn R.F. Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease. Neurosci Lett. 187:(1):1995;5-8.
21. Breitner J.C.S., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J., Anthony J.C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin study. Neurology. 44:1994;227-232.
22. Brugg B., Dubreuil Y.L., Hubert G., Wollman E.E., Delhaye-Bouchad N., Mariani J. Inflammatory processes induce β-Amyloid precursor protein changes in mouse brain. Proc the Natl Acad Sci USA. 92:1995;3032-3035.
23. Buttini M., Limonta S., Boddeke H.W.G.M. Peripheral administration of lippopolysaccharide induces activation of microglial cells in rat brain. Neurochem Int. 29:(1):1996;25-35.
24. Carlson S.L., Beiting D.J., Kiani C.A., Ambell K.M., McGillis J.P. Catecholamines decrease lymphocyte adhesion to cytokine-activated endothelial cell. Brain Beh Immun. 10:1996;55-67.
25. Chao C.C., Hu S. Tumor necrosis factor-α potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci. 16:1994;172-179.
26. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Inerleukin-1 and Tumor Necrosis Factor-α synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-Methyl-D-aspartate receptors, Brain. Beh Immun. 9:1995;355-365.
27. Chao C.C., Hu S., Peterson P. Glia: the not so innocent bystanders. J NeuroVirology. 2:1996;234-239.
28. Chao CC, Hu S, Peterson PK. Glia-mediated neurotoxicity. In: Peterson PK, Remington JS, editors. In Defense of the Brain. Oxford: Blackwell, 1997. p. 74-89.
29. Chen S., Frederickson R.C., Brunden K.R. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches. Neurobiol Aging. 17:(5):1996;781-787.
30. Connor T.J., Leonard B.E. Depression stress immunological activation: the role of cytokines in depressive disorders. Life Sci. 62:(7):1998;583-606.
31. Cooper A.L., Rothwell N.J. Mechanisms of early and late hypermetabolism and fever after localized tissue injury in rats. Am J Physiol. 261:1991;E698-E705.
32. Dantzer R, Bluthe R, Aubert A, Goodall J, Bret-Dibat J, Kent S, Goujon E, Laye S, Aprnet P, Kelley K. Cytokine actions on behavior. In: Rothwell NJ, editor. Cytokines in the Nervous System. Austin: R.G. Lands Co., 1996. p. 127-130.
33. Danzter R, Bluthe R, Kent S, Kelley K. Behavioral effects of cytokines. In: Rothwell NJ, Danzter R, editors. Interleukin-1 in the Brain. Oxford: Permagon Press, 1992. p. 135-147.
34. Dawson T.M., Dawson V.L., Snyder H. Molecular mechanisms of nitric oxide actions in the brain. Ann N Y Acad Sci. 738:1994;76-85.
35. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA. 88:(14):1991;6368-6371.
36. De Luca B., Monda M., Sullo A. Changes in eating behavior and thermodynamic activity following inhibition of nitric oxide formation. Am J Physiol. 268:(6):1995;1533-1538.
37. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:(6665):1998;387-390.
38. Denicoff K.D., Rubinow D.R., Papa M.Z., Simpson C., Seipp C.A., Lotze M.T., Chang A.E., Rosenstein D., Rosenberg S.A. The neuropsychiatric effects of treatment with IL-2 and lymphokine-activated killer cells. Ann Intern Med. 107:1987;293-300.
39. Dewji N.N., Do C., Singer S.J. On the spurious endoproteolytic processing of the presenilin proteins in cultured cells and tissues. Proc Natl Acad Sci USA. 94:(25):1997;14031-14036.
40. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.C., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
41. Drobniewski F., Kelly P., Ngwenya C.B., Luo N., Pankhurst C., Farthing M. Human astrocytes inhibit intracellular growth of toxoplasmosa gondii by a nitric oxide-mediated mechanism. J Infect Dis. 171:1995;516-518.
42. Dubovik V., Faigon M., Feldon S., Michaelson D.M. Decreased density of forebrain cholinergic neurons in experimental autoimmune dementia. Neurosci. 56:(1):1995;75-82.
43. Eikelenboom P., Abraham C.R. Immunologic factors in Alzheimer's disease. Res Immunol. 143:1992;613-683.
44. Eikelenboom P., Rozemuller J.M., Kraal G., Stam F.C., McBride P.A., Bruce M.E., Fraser H. Cerebral amyloid plaques in Alzheimer's disease but not scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch B Cell Pathol. 60:1991;329-336.
45. Eikelenboom P., Zhan S.S., van Gool A., Allsop D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci. 15:(12):1995;447-450.
46. Ellison M.D., Povlishock J.P., Merchant R.E. Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion. Cancer Res. 47:1987;5765-5770.
47. Elmquist J.K., Scammel T.E., Saper C.B. Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurisci. 20:1997;565-570.
48. Fabian R.H., Rea H.C. Neuronal toxicity in macrophages in mixed brain culture is augmented by antineuronal IgG and dependent upon nitric oxide synthesis. J Neuroimmunol. 44:1993;95-102.
49. Felten DL, Cohen N, Ader R, Felten SY, Carlson SL, Roszman TL. Central neural circuits involved in neural-immune interactions. In: Ader R, Felton DL, Cohen N, editors. Psychoneuroimmunology. London: Academic Press, 1991. p. 3-19.
50. Fleshner M., Goehler L.E., Schwartz B.A., McGorry M., Martin D., Maier S.F., Watkins L.R. Thermogenic and corticosterone responses to intravenous cytokines (IL-1β and TNF-α) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol. 86:1998;134-141.
51. Fontana A, Constam D, Frei K, Koedel U, Pfister W, Weller M. In: Ranshoff RM, Benveniste EN, editors. Cytokines and the CNS, Boca Raton: CRC Press, 1996. p. 205-207.
52. Forster MJ, Lal H. Autoimmunity and cognitive decline in aging and Alzheimer's disease. In: Ader R, Felton DL, Cohen N, editors. Psychoneuroimmunology. London: Academic Press, 1991. p. 718-728.
53. Friedman E.M., Reyes T.M., Coe C.L. Context-dependent behavioral effects of Interleukin-1 in the rhesus monkey (macaca mulatta). Psychoneuroendocrinology. 21:(5):1996;455-468.
54. Fudenberg H.H., Whitten H.D., Arnaud P., Khansari N. Is Alzheimer's disease an immunological disorder? Observations and speculations. Clin Immunol Immunopathol. 32:(2):1984;127-131.
55. Ganter U., Strauss S., Jonas U, Weidmann A., Beyreuther K., Volk B., Berger M., Bauer J. Alpha 2-macroglubulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein. Febs Let. 282:(1):1991;127-131.
56. Geldmacher D.S., Whitehouse P.H. Differential diagnosis of Alzheimer's disease. Neurology. 48:(Suppl. 6):1997;s2-s9.
57. Gibertini M., Newton C., Friedman H., Klien T. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous Interleukin-1. Brain Behav Immun. 9:1995;113-128.
58. Goldbach J.M., Zeisberger R.E. Role of the vagus nerve in transmission of signals from the immune system to brain structures involved in the induction of fever. Neuroimmunomodulation. 3:1996;310-320.
59. Goowdin RG, Cerretti DP, Smith CA. Cytokine Receptors. In: Ransohoff RM, Benveniste EN, editors. Cytokines in the Central Nervous System, New York: CRC Press, 1996. p. 4-16.
60. Hailer N.P., Bechmann I., Heizmann S., Nitch R. Adhesion molecule expression on phagocytic microglial cells following anterograde degeneration of perforant path axons Hippocampus. 7:(3):1997;341-349.
61. Hamilton TA, Tannenbaum CS, Tebo JM. In: Ransohoff RM, Benveniste EN, editors. Cytokines in the Central Nervous System. New York: CRC Press, 1996. p. 25-46.
62. Hanisch U., Seto D., Quirion R. Modulation of hippocampal ACh release: a potent central action for IL-2. J Neurosci. 13:(8):1993;3368-3374.
63. Harque S.J., Williams R.G. Signal transduction in the interferon system. Semin Oncol. 25:(1):1998;14-22.
64. Hart S, Semple JM. Neuropsychology and the Dementias. London, UK: Taylor and Francis, 1990.
65. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780:(2):1998;294-303.
66. Heppner F.L., Roth K., Nitsch R., Hailer N.P. Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells. Glia. 22:(2):1998;180-188.
67. Heyser C.J., Masliah E., Samimi A., Campbell I., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in mice expressing interleukin-6 in the brain. Proc Natl Acad Sci USA. 94:1997;1500-1505.
68. Hickey WF. Leukocyte migration into the central nervous system. In: Peterson PK, Remington JS, editors. In Defence of the Brain. Oxford: Blackwell, 1997. p. 11-30.
69. Holden R.J., Mooney P.A. Interleukin-1β: a common cause of Alzheimer's disease and diabetes mellitus. Med Hypotheses. 45:1995;559-571.
70. Holliday J., Gruol D.L. Cytokine stimulation increases intracellular Ca2+ and alters the response to quisqualate in cultured cortical astrocytes. Brain Res. 61:1993;233-241.
71. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system I: expression and recognition. Trends Neurosci. 18:1995;83-88.
72. Houlden H., Crook R., Backhovens H., Prihar G., Baker M., Hutton M., Rossor M., Martin J.J., Van Broeckhoven C., Hardy J. ApoE genotype is a risk factor in nonpresenilin early ons Alzheimer's disease families. Am J Med Genet. 81:(1):1998;117-121.
73. Hsiao K., Chapman P., Nilsen N., Exkman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, A-beta elevation and amyloid plaques in transgenic mice. Science. 274:(5284):1996;99-102.
74. Ingram D.K., Spangler E.L., Iijima S., Ikara H., Kuo H., Greig N.H., London E.D. Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis. Life Sci. 55:(25/26):1994;2037-2049.
75. Ishii T., Haga S. Complementsmicroglial cells amyloid fibril formation. Res Immunol. 143:1992;614-616.
76. Johnson R.T. The pathogenesis of HIV infections of the brain. Curr Top Microbiol Immunol. 202:1995;3-10.
77. Jordan J., Galindo M.F., Miller M.F., Reardon C.A., Getz G.S., LaDu M.J. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci. 18:(1):1998;195-204.
78. Juurlink B.H. Response of glial cells to ischemia: Roles of reactive oxygen species and glutatione. Neurosci Biobehav Rev. 21:(2):1997;151-166.
79. Katsuki H., Nakai S., Hirao Y., Akaji K., Kiso Y., Satoh M. Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol. 181:1990;323-326.
80. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol. 42:1985;1097-1105.
81. Kim T., Pettingell W.H., Jung Y., Kovacs D.M., Tanzi R.E. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science. 277:1997;373-376.
82. Kingston I., Castro M., Anderson S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nature Med. 1:1995;138-142.
83. Klegeris A., Walker D.G., McGeer P.L. Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells. J Neuroimmunol. 78:(1/2):1997;152-161.
84. Klegeris A., McGeer P.L. β-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res. 49:1997;229-235.
85. Klegeris A., Walker D.G., McGeer E.G., MgGeer P.L. Glutamate in co-cultures of human monocytic and astrocytoma cells: effects of inflammatory mediators amyloid β peptide and anti-inflammatory drugs. Society for Neuroscience Abstract. 23:(2):1997;24-28.
86. Klegeris A., Walker D.G., McGeer P.L. Interaction of Alzhemier β-amyloid peptide with the human monocyte cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α Brain Res. 747:1997;114-121.
87. Kostoglou-Athanassiou I., Costa A., Navarra P., Nappi G., Forsling M.L., Grossman A.B. Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide. J Neuroimmunol. 86:1998;104-109.
88. Krzanoski J.J. Microglia and immune activation in Alzheimer's disease. J Fla Med Assoc. 80:(4):1993;267-2269.
89. Kuiper M.A., Visser J.J., Bergmans P.L., Scheltens P., Wolters E.C. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. J Neurol Sci. 121:(1):1994;46-49.
90. LaDu M.J., Falduto M.T., Manelli A.M., Reardon C.A., Getz G.S., Frail D.E. Isoform-specific binding of apolipoprotein to β-amyloid. J Biol Chem. 269:1994;23403-23406.
91. Landis DMD. Brain as tissue: the interacting cell populations of the central nervous system. In: Ranshoff RM, Benveniste EN, editors. Cytokines and the CNS. New York: CRC Press, 1996. p. 63-83.
92. Lapchak P.A., Araujo D.M., Quirion R., Beadet A. Immunoautoradiographic localization of IL-2-like immunoreactivity and IL-2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neurosci. 44:(1):1991;173-184.
93. Lee S.C., Dickson D.W., Brosnan C.F., Casadevall A. Human astrocytes inhibit Cryptococcus Neoformans growth by a nitric oxide-mediated mechanism. J Exp Med. 180:1994;365-369.
94. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., Berman J.W. Cytokine production by human fetal microglia and astrocytes. J Immunol. 150:1993;2659-2667.
95. Li M., Sunamoto M., Ohnishi K., Ichiori Y. Beta-amyloid protein dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:(1-2):1996;93-100.
96. Li S., Mallory M., Alford M., Tanaka S., Masliah E. Glutamate transporter alterations in Alzheimer's disease are possibly associated with abnormal APP expression. J Neuropath Exper Neurol. 56:(8):1997;901-911.
97. Licinio J., Kling M.A., Hauser P. Cytokines and brain function: relevance to interferon-γ-induced mood and cognitive changes. Semin Oncol. 25:(1):1998;30-38.
98. Licinio J., Seibyl J.P., Altemus M., Charney D.S., Krystal J.H. Elevated CSN levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry. 150:1993;1408-1410.
99. Lipovsky M.M., Gekker G., Anderson W.R., Molitor T.W., Peterson P.K., Hopelman A.I. Phagocytosis of nonopsonized cryptococcus neoformans by swine microglia involves CD14 receptors. Clin Immunol Immunopathol. 84:(2):1997;208-211.
100. Luheshi G.N., Hammond E., van Dam A.M. Cytokines as messengers of neuroimmune interactions. Trends Neurosci. 19:(2):1996;46-47.
101. Mayeux R., Saunders A.M., Shea S., Mirra S., Evans D., Roses A.D., Hyman B.T., Crain B., Tang M.X., Phelps C.H. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. New England Journal of Medicine. 338:(8):1998;506-511.
102. McAllister C.G., van Kammen D.P., Rehn T.J., Miller A.L., Gurklis J., Kelley M.E., Yao J., Peters J.L. Increases in CSF levels of interleukin-2 in Schizophrenia: effects of recurrence and medication status. Am J Psychiatry. 152:1995;1291-1297.
103. McDonald M.P., Overmier J.B., Bandyopadhyay S., Babcock D., Cleary J. Reversal of beta-amyloid-induced retention deficit after exposure to training state cues. Neurobiol Learn and Mem. 65:(1):1996;35-47.
104. McGeer P.L., McGeer E.G. Complement proteins and complement inhibitors in Alzheimer's disease. Res Immunol. 143:1992;621-623.
105. McGeer P.L., Rogers J. Antiinflammatory agents as a therapeutic approach to Alzheimer's disease. Neurol. 42:1992;447-449.
106. McMillian M., Kong L., Sawin S.M., Wilson B., Das K., Hudson P., Hong J., Bing G. Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem Biophys Res Commun. 215:(2):1995;572-577.
107. Meda L., Bonaito V., Baron P., Otvos L. Jr., Rossi F., Cassatella M.A. Priming of monocyte respiratory burst by beta-amyloid fragment (25-35). Neurosci Lett. 219:(2):1996;91-94.
108. Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Ferrari D., Rossi F. Activation of microglia cells by β-Amyloid protein and interferon-γ Nature. 374:1995;647-649.
109. Medina J.H., Izquierdo I. Retrograde messengers, LTP and memory. Brain Res Rev. 21:(2):1995;185-194.
110. Merrill J.E., Murphy S. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines and chemokines by reactive nitrogen and oxygen species. Brain Behav Immun. 11:1997;245-263.
111. Miller B., Sarantis M., Traynelis S.F., Attwell D. Potentiations of NMDA receptor currents by arachidonic acid. Nature. 335:1992;922-925.
112. Milstein S., Sakai N., Brew B.J., Krieger C., Vickers J.H., Saito K., Heyes M.P. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J Neurochem. 63:(3):1994;1178-1180.
113. Mirra S.S., Hart M.N., Terry R.D. Making the diagnosis of Alzheimer's disease: A primer for practicing pathologists. Arch Pathol Lab Med. 117:1993;132-144.
114. Mitrovic B., Martin F.C., Charles A., Ignaroo L.J., Anton P.A., Shanaham F., Merill J.E. Neurotransmitters and cytokines in CNS pathology. Prog Brain Res. 103:1994;319-330.
115. Molina-Holgado F., Guaza C. Endotoxin administration induced differential neurochemical activation of the rat brain stem nuclei. Brain Res Bull. 40:(3):1996;151-156.
116. Montero-Menei C.N., Sindji L., Garcion E., Mege M., Couez D., Gamelin E., Darcy F. Early events of the inflammatory reaction induced in rat brain by lippopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Res. 724:1996;55-66.
117. Myslivecek J., Hassmannova J., Baracal J., Safanda J., Zalud V. Inhibitory learning and memory in new born rats influenced by nitric oxide. Neurosci. 71:(2):1996;299-312.
118. Nathan C. Nitric oxide as a secretory product of mammalian cells. Faseb J. 6:1992;3051-3064.
119. Navarro J.A., Molina J.A., Jimenez F.J., Benito-Leon J., Orti-Pareja M., Gasalla T., Cabrera-Valdivia F., Vargas C., de Bustos F., Arenas J. Cerebrospinal fluid nitrate levels in patients with Alzheimer's Disease. Acta Neurol Scand. 94:(6):1996;411-414.
120. Nistico G., DeSarro G. Is interleukin-2 a neuromodulator in the brain? Trends Neurosci. 14:(4):1991;146-150.
121. Noda Y., Yamada K., Nabeshima T. Role of nitric oxide in the effects of aging on spatial memory in rats. Behav Brain Res. 83:(1-2):1997;153-158.
122. Nottet H.S.L.M., Gendelman H.E. Unravelling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today. 16:(9):1995;441-448.
123. O'Grady MP, Hall NS. Long-term effects of neuroendocrine-immune interactions during early development, In: Ader R, Felton DL, Cohen N, editors. Psychoneuroimmunology. London: Academic Press, 1991. p. 561-569.
124. Ohno M., Yamamoto T., Watanabe S. Deficits in working memory following inhibition of hippocampal nitric oxide synthesis in the rat. Brain Res. 632:(1-2):1993;36-40.
125. Ohno M., Yamamoto T., Watanabe S. Intrahippocampal administration of the NO synthase inhibitor L-NAME prevents working memory deficits in rats exposed to transient cerebral ischemia. Brain Res. 634:1994;173-177.
126. Oitzl M.S., van Oers H., Schobitz B., de Kloet R. Interleukin-1 but not interleukin-6, impairs spatial navigation learning. Brain Res. 613:1993;160-163.
127. Oken R.J. Towards a unifying hypothesis of neurodegenerative diseases and a concomitant rational strategy for their prophylaxis and therapy. Med Hypotheses. 45:1995;341-342.
128. Otsubo T., Miyaoka H., Kamijima K., Onuki M., Mitamura K. Depression during interferon therapy in chronic hepatitis C patients-a prospective study (Japanese, abstract in English). Psychiatr Neurol Jap. 99:(3):1997;101-127.
129. Paakkari L., Lindsberg P. Nitric Oxide in the central nervous system. Ann Med. 27:1995;369-377.
130. Perlmutter L.S., Scott S.A., Barron E., Chui H.C. MHC class II-positive microglia in human brain: association with Alzheimer's disease lesions. J Neurosci Res. 33:1992;549-558.
131. Perry V.H., Anderson P., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:(7):1993;268-275.
132. Perry V.H., Gordon S. Macrophages and the nervous system. Int Rev Cytol. 125:1991;203-244.
133. Peterson P.K., Gekker G., Hu S., Chao C.C. Human astrocytes inhibit intracellular growth of Toxoplasma gondii by a nitric oxide-mediated mechanism. J Infect Dis. 171:1995;516-518.
134. Piani D., Frei K., Do K.Q., Cuenod M., Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett. 133:1991;159-162.
135. Piani D., Frei K., Pfister H., Fontana A. Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J Neuroimmunol. 48:1993;99-104.
136. Poutiainen E., Hokkanen L., Niemi M.-L., Forkkil M. Reversible cognitive decline during high-dose α-interferon treatment. Pharmacol Biochem Behav. 47:(4):1994;901-905.
137. Price D.L., Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci. 21:1998;479-505.
138. Rebeck G.W., Marzloff K., Hyman B.T. The pattern of NADPH-diaphorase staining, a marker of nitric oxide synthase activity, is altered in the perforant pathway terminal zone in Alzheimer's disease. Neurosci Lett. 151:(1-2):1993;165-168.
139. Rich J.B., Rasmusson D.X., Folstein M.F., Carson K.A., Kawas C., Brandt J. Non-steroidal anti-inflammatory drugs in Alzheimer's disease. Neurology. 45:1995;51-55.
140. Roberts G.W., Gentleman S.M., Lynch A., Landon M., Graham D.I. β-amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 57:1994;419-425.
141. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P., Kogan F. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
142. Rogove A.D., Tsirka S.E. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol. 8:(1):1998;19-25.
143. Rosenberg R.N., Baskin F., Fosmire J.A., Risser R., Adams P., Svetlik D., Honig L.S., Cullum C.M., Weiner M.F. Altered amyloid protein processing in platelets of patients with Alzheimer's disease. Arch Neurol. 54:(2):1997;139-144.
144. Rothwell N.J. Interleukin-1 and neurodegeneration. The Neuroscientist. 4:(3):1998;195-201.
145. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18:1995;130-136.
146. Rozemuller J.M., Eikelenboom P., Pals S.T., Stam F.C. Microglial cells around amyloid plaques in Alzheimer's disease express leukocyte adhesion molecules of the LFA-1 family. Neurosci Lett. 101:1989;288-292.
147. Rozemuller J.M., van der Valk P., Eikelenboom P. Activated microglia and cerebral amyloid deposits in Alzheimer's disease. Res Immunol. 143:1992;646-649.
148. Saper C.B., Breeder C.D. Endogenous Pyrogens in the CNS: role in the febrile response. Prog Brain Res. 93:1992;419-428.
149. Seeger G., Hartig W., Rossner S., Schiebs R., Bruckner G., Bigl V., Brauer K. Electron microscopic evidence for microglial phagocytosis and cholinergic cell death after administration of the immunotoxin 192IgG-saporin in rat. J Neurosci Res. 48:(5):1997;465-476.
150. Segal M. Morphological alternations in dendritic spines of rat hippocampal neurons exposed to NMDA. Neurosci Lett. 193:1995;73-76.
151. Shen Y., Li R., McGeer E.G., McGeer P.L. Neuronal expression of mRNA for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769:(2):1997;391-395.
152. Sihver W., Gunther P., Schliebs R., Gigl V. Repeated administration of tacrine to normal rats: effects on cholinergic, glutaminergic and GABAergic receptor subtypes in rat brain using receptor autoradiography. Neurochem Int. 31:(5):1997;693-703.
153. Skaper S.D., Facci L., Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J Neurochem. 64:1995;266-276.
154. Slepko N., Minghetti L., Polazzi E., Nicolini A., Levi G. Reorientation of prostanoid production accompanies "activation" of adult microglial cells in culture. J Neurosci Res. 49:(3):1997;292-300.
155. Smith A., Tyrell D., Coyle K, Higgins P. Effects of interferon alpha on performance in man: a preliminary report. Psychopharmacology. 96:1988;414-416.
156. Smith C.C.T., Bowen D.M., Francis P.T., Snowden J.S., Neary D. Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry. 48:1985;469-471.
157. Smith R.S., Maes M. The macrophage, T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses. 45:1995;135-141.
158. Streit W., Kincaid-Colton C. The brain's immune system. Sci Am. 273:(5):1995;54-61.
159. Strite D., Valentine A.D., Meyers C.A. Manic episodes in two patients treated with interferon alpha. J Neuropsychiatry Clin Neurosci. 9:(2):1997;273-276.
160. Svensson M., Liu L., Mattsson P., Morgan B.P., Aldskogius H. Evidence for activation of the terminal pathway of complement and upregulation of sulfated glycoprotein (SGP)-2 in the hypoglossal nucleus following peripheral nerve injury. Mol Chem Neuropathol. 24:(1):1995;53-68.
161. Toulmond S., Parnet P., Linthorst A.C.E. When cytokines get on your nerves: cytokine networks and CNS pathologies. Trends Neurosci. 19:1996;409-410.
162. Tsirka S.E. Clinical implications of the involvement of tPA in neuronal cell death. J Mol Med. 75:1997;341-347.
163. Tsirka S.E., Rogove A.D., Bugge T.H., Degen J.L., Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci. 17:(2):1997;532-543.
164. Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease caused by an IL-1/IL-6-mediated acute phase response in the brain? Immunol Today. 12:(7):1991;217-219.
165. von Zahn J., Moller T., Kettenmann H., Nolte C. Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines. Neuroreport. 8:(18):1997;3851-3856.
166. Walker D.G., Kim S.U., McGeer P.L. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res. 40:1995;478-493.
167. Walker L.G., Wesnes K.P., Heys S.D., Walker M.B., Lolley L., Eremin O. Cognitive effects of rIL-2 therapy: a controlled clinical trial using computerized assessments. Eur J Cancer A. 32:(13):1996;2275-2283.
168. Walsh T.J., Herzog C.D., Gandhi C., Stackman R.W., Wiley R.G. Injection if IgG 192-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits. Brain Res. 726:1996;69-79.
169. Weldon D.T., Rogers S.D., Ghilardi J.R., Finke M.P., Cleary J.P., O'Hare E., Esler W.P., Maggio J.E., Mantyh P.W. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase and loss of a select population of neurons in the rat CNS in vivo. J Neurosci. 18:(6):1998;2161-2173.
170. Wesselingh SL, Tyor W, Griffin DE, Cytokines and HIV-associated dementia. In: Ranshoff RM, Benveniste ENeditors. Cytokines and the CNS. New York: CRC Press, 1996. p. 287-307.
171. Williams K.C., Hickey W.F. Traffic of hematogenous cells through the central nervous system. Curr Top Microbiol Immunol. 202:1995;221-245.
172. Wisnieski H.M., Wegiel J. The role of perivascular microglial cells in fibrillogenesis of β-amyloid and PrP protein in Alzheimer's disease and scrapie. Res Immunol. 143:1992;642-643.
173. Wollman EE, Koomels B, Bakalian A, Delhaye-Bouchad N, Fradelizi D, Mariani J. Cytokines and neuronal degeneration. In: Rothwell NJ, Dantzer R, editors. Interleukin-1 in the Brain. Oxford: Permagom Press, 1992. p. 187-203.
174. Wong M, Al-Shekhlee A, Gold PW, Lucinio J. In: Rothwell NJ, editor. Cytokines in the Brain. Cytokines in the Nervous System, Austin. TX: R.G. Landes, 1996. p. 3-13.
175. Yamada K., Noda Y.M., Hasegawa T., Komori Y.Q., Nikai T., Sugihara H., Nabeshima T. The role of nitric oxide in dizocilpine-induced imapirment in spontaneous alternation in mice. J Pharmacol Exp Ther. 276:(2):1996;460-466.
176. Yamaguchi H., Hirai S., Morimatsu M., Shoji M., Harigawa Y. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol. 77:1988;113-119.
177. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Mighell A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
178. Yoshioka M., Bradley W.G., Shapshak P., Nagano I., Stewart R.V., Xin K., Srivastava A.K., Nakamura S. Role of immune activation and cytokine expression in HIV-1-associated neurologic disease. Adv Neuroimmunol. 5:1995;335-358.
179. Zachary J.F., Baszler T.V., French R.A., Kelley K.W. Mouse moloney leukemia virus infects microglia but not neurons even though it induces motor neuron disease. Mol Psychiatry. 2:(2):1997;104-106.
180. Zuckerman S.H., Gustin J., Evans G.F. Expression of CD54 (intercellular adhesion molecule-1) and the beta 1 integrin CD29 is modulated by a cyclic AMP dependent pathway in activated primary rat microglial cell cultures. Inflammation. 22:(1):1998;95-106.
181. Tyor W.R., Glass J.D., Griffin J.W. Ann Neurol. 31:(4):1992;349-360.
182. Yoshioka M., Shapshak P., Nakamura S., Nagano I., Nelson S.J., Kogure K. Neurology. 42:(Suppl. 3):1992;236.
183. An S.F., Ciardi A., Giometto B., Scaravilli T., Gray F., Scaravilli F. Acta Neuropathol. 91:(5):1996;494-503.
184. Meistrell M.E. 3rd, Botchkina G.I., Wang H., DiSanto E., Cockroft K.M., Bloom O., Vishnubhakat J.M., Ghezzi P., Tracey K.J. Shock. 8:(5):1997;341-348.
185. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-hur T. J Neuroimmunol. 72:(2):1997;169-177.
186. Tarkowski E., Rosengren L., Bloomstrand C., Wikkelso C., Jensen C., Ekholm S., Tarkowski A. Clin ExpImmunol. 110:(3):1997;492-499.
187. Wisniewski T., Lalowski M., Baumann M., Rauvala H., Raulo E., Nolo R., Frangione B. Neuroreport. 7:(2):1996;667-671.
188. Shalit F., Sredni B., Stern L., Kott E., Huberman M. Neurosci Lett. 174:1994;130-132.
189. Bauer J., Strauss S., Scheiter-Gasser U., Ganter U., Schlegel P., Witt I., Yolk B., Berger M. Febs L. 285:(1):1991;111-114.
190. Sarchielli P., Orlacchio A., Vicinanza F., Pelliccioli G.P., Tognoloni M., Saccardi C., Gallai V. J Neuroimmunol. 80:(1-2):1997;76-86.
191. Maimone D., Guazzi G.C., Annunziata P. J Neurol Sci. 146:(1):1997;59-65.
192. Maes M., Meltzer H.Y., Bosmans E. Acta Psychiatr Scand. 89:1994;346-351.
193. Naudin J., Capo C., Giusano B., Azorin J.M. Schizophr Res. 26:(2-3):1997;227-233.
194. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Cytokine. 9:(11):1997;853-858.
195. Kordek R., Nerurkar V.R., Liberski P.P., Issacson S., Yanagihara R., Gajdusek D.C. Proc Natl Acad Sci USA. 93:(18):1996;9754-9758.
196. Gupta S., Aggarwal S., See D., Starr A. J Psychiatr Res. 31:(1):1997;149-156.
197. Chao C.C., Janoff E.N., Hu S., Thomas K., Gallagher M., Tsang M., Peterson P.K. Cytokine. 3:(4):1991;292-298.